The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It’s not 200m to management team the vast majority of the options was going to management team not the board, the management team ard we also paying 0.4 or 0.5p for most of these shares!….this is normal practice on loads of companies I’ve been invested in…
Option Schedule
122,500,000 of the Director Options and 202,500,000 Management Options will be exercisable and converted into ordinary shares in the Company at a nil cost on the sooner of 31 May 2023 or completion of the Definitive Feasibility Study at the Zulu Lithium Project.
65,000,000 of the Director Options and 202,500,000 Management Options will be exercisable and converted into ordinary shares in shares in the Company from1 December 2023 at a price 0.4p.
65,000,000 of the Director Options and 202,500,000 Management Options will be exercisable and converted into ordinary shares in shares in the Company from 31 May 2024 at a price 0.5p.
65,000,000 of the Director Options and 202,500,000 Management Options will be exercisable and converted into ordinary shares in shares in the Company from 1 December 2024 at a price 0.5p.
Great post happyhols, week by week, month by month the risk with prem is decreasing…very happy to carry on holding until we get into production, which has been my intention since GR correctly held onto 100% of the asset rather than selling out or JVing too early and too cheap! Well played GR!
Game changer RNS for prem, gonna be properly capitalised for once and has a client/significant shareholder with industry experience chomping at the bit for the spodumene in the ground. Bara report seems to indicate they are going for the low hanging fruit first to derisk the borrowing position. Very very happy with how things are shaping up. GnT time, have a good weekend all
Bick, interesting analysis so you think we c7-9 bag from here on your numbers…..I’m more than happy with that! Nothing wrong in using fairly conservative numbers at this point…..when Prem gives us a clearer steer on what the cunning plan is going forward we can then perhaps amend upwards. What’s interesting to note is most here think this share price is going significantly up which is a nice change!
Few days here or there isn’t an issue as long as the message is good! I think you need to accept GR timelines are not that often hit……once thats accepted it’s a lot easier to be chilled. I’m all for delaying the rns until markets look a bit rosier anyway!
Struggling to work out what our Chinese offtaker timelines are going to be:-
Option A - George take as long as you like, no rush buddy
Option B - structural deficit in supply of spodumene coming up maybes we ought to get on with it
Mmmmm……..very tricky to know how they are gonna want to play this
Pre-emptions rights discussed last night simply means Suzhou have right not to be diluted below 13.38% if prem issues more shares.
They would need Matching rights if they were to be able to offer the same consideration amount as another party willing to buy into zulu….no where in the rns can I see that they have matching rights.
Hopefully that puts that one to bed.
Spot on Jenkoo, fantastic summary…. I strongly believe inexperienced investors get spooked by these share price movements because they assume the share price reflects the company assets or the companies worth.
They very rarely tally!
New investors would do well to watch a few warren buffett interviews on say YouTube, in my opinio it will save them a few quid - would have saved me a
Bundle in my early investing life